Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil

dc.creatorSá, Nathalia Beatriz Ramos de
dc.creatorGoulart, Milena Neira
dc.creatorAlves, Marcelo Ribeiro
dc.creatorPerazzo, Hugo
dc.creatorGeraldo, Kim Mattos
dc.creatorRibeiro, Maria Pia Diniz
dc.creatorCardoso, Sandra Wagner
dc.creatorGrinsztejn, Beatriz
dc.creatorVeloso, Valdiléa G.
dc.creatorCapão, Artur
dc.creatorSiqueira, Marilda Mendonça
dc.creatorBezerra, Ohanna Cavalcanti de Lima
dc.creatorGarcia, Cristiana Couto
dc.creatorGomes, Larissa Rodrigues
dc.creatorCazote, Andressa da Silva
dc.creatorAlmeida, Dalziza Victalina de
dc.creatorGiacoia-Gripp, Carmem Beatriz Wagner
dc.creatorCôrtes, Fernanda Heloise
dc.creatorMorgado, Mariza Gonçalves
dc.date.accessioned2022-10-11T12:06:48Z
dc.date.accessioned2022-10-12T15:28:20Z
dc.date.available2022-10-11T12:06:48Z
dc.date.available2022-10-12T15:28:20Z
dc.date.created2022-10-11T12:06:48Z
dc.date.issued2022
dc.identifierSÁ, Nathalia Beatriz Ramos de et al. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil. BioMed Research International, v.2022, Article 9082455, p. 1 - 15, 2022.
dc.identifier2314-6133
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/55097
dc.identifier10.1155/2022/9082455
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4091828
dc.languageeng
dc.publisherHindawi
dc.rightsopen access
dc.titleInflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil
dc.typeArticle


Este ítem pertenece a la siguiente institución